ImmuPharma plc (IMM.L) on TheBioTechPanel-TV.com
7/10/2012 8:40:45 AM
More...
|
ImmuPharma plc (IMM.L)'s Lupuzor™ Granted Approval to Start Phase III and Fast Track Designation by the FDA
11/3/2011 8:43:34 AM
More...
|
ImmuPharma plc (IMM.L) Regains Lupuzor Rights from Cephalon, Inc. (CEPH) Due to Teva Pharmaceutical Industries Limited (TEVA) Merger
10/21/2011 6:59:23 AM
More...
|
ImmuPharma plc (IMM.L) - Preliminary Results for the Year Ended 31 December 2010
4/5/2011 8:47:34 AM
More...
|
ImmuPharma plc (IMM.L) - Notification of Preliminary Results
3/30/2011 9:34:53 AM
More...
|
ImmuPharma plc (IMM.L) - Update on Progress of Phase I/IIa Clinical Trial
2/22/2011 10:52:55 AM
More...
|
ImmuPharma plc (IMM.L) Release: Preliminary Results Announcement For The Year Ended 31 December 2009
5/19/2010 2:53:07 PM
More...
|
ING Takes 4% Stake In ImmuPharma plc (IMM.L)
1/13/2010 10:20:46 AM
More...
|
ImmuPharma plc (IMM.L) CEO Slams Stock Plunge After Drug Trial
11/19/2009 8:18:04 AM
More...
|
ImmuPharma plc (IMM.L) Swings to H1 Profit After Cephalon, Inc. (CEPH) Deal
9/29/2009 7:13:49 AM
More...
|
|